Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A Dublin group has developed a high-throughput method for analyzing sugar structures on proteins, which they hope will open up the arcane field of glycan analysis to a wider audience.
Chemical biology graduate programs that are jointly organized by chemistry and life science departments can offer a stimulating 'bicultural' training environment for students from diverse backgrounds. However, communication, flexibility and responsiveness are crucial for effectively structuring such programs.
A think tank and an investment bank have proposed solutions to address the lack of funding to carry biotech companies through the early stages of clinical development.
To reduce unacceptably high death rates from snakebite envenomation, sub-Saharan Africa must adopt not only a new generation of multivalent biotech antivenoms, but also an infrastructure to deliver them.
Five years after the US anthrax attacks, and more than two years after BioShield legislation was ratified, a survey reveals that biodefense funding has thus far produced only a handful of products for clinical development.
The Chairman of The President's Council on Bioethics talks about why scientists and policymakers would be wise to draw on both religion and reason in that endeavor.